Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Hyperprolactinemia × Cabergoline × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Pituitary Neoplasms 6 Prolactinoma 5 Pituitary ACTH Hypersecretion 3 Polycystic Ovary Syndrome 2 Acromegaly 2 Recurrence 1 Prostatic Neoplasms 1 Ovarian Hyperstimulation Syndrome 1 Neuroendocrine Tumors 1 Neoplasms 1 Melanoma 1 Hyperprolactinemia 1 Heart Valve Diseases 1 Dumping Syndrome 1 Breast Neoplasms 1 Brain Neoplasms 1 Adrenocortical Hyperfunction 1 ACTH-Secreting Pituitary Adenoma 1

Interventions

ropinirole 1 Clomiphene 1 Cabergoline 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT07463235 2026-03-13

SPARAGMOS

University of Sao Paulo General Hospital

Phase 3 Recruiting

Hyperprolactinemia, Prolactinoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡